Please use this identifier to cite or link to this item: http://digitalrepository.fccollege.edu.pk/handle/123456789/1933
Full metadata record
DC FieldValueLanguage
dc.contributor.authorYousaf, Muhammad Zubair-
dc.contributor.authorIdrees, Muhammad-
dc.contributor.authorSaleem, Zafar-
dc.contributor.authorRehman, Irshad U.-
dc.contributor.authorAli, Muhammad-
dc.date.accessioned2023-11-22T07:03:24Z-
dc.date.available2023-11-22T07:03:24Z-
dc.date.issued2011-
dc.identifier.citationYousaf, M.Z., Idrees, M., Saleem, Z. et al. Expression of core antigen of HCV genotype 3a and its evaluation as screening agent for HCV infection in Pakistan. Virol J 8, 364 (2011). https://doi.org/10.1186/1743-422X-8-364en_US
dc.identifier.issn1743-422X-
dc.identifier.uri10.11.12.71:8080/jspui/handle/123456789/1933-
dc.description.abstractBackground Pakistan is facing a threat from hepatitis C infection which is increasing at an alarming rate throughout the country. More specific and sensitive screening assays are needed to timely and correctly diagnose this infection. Methods After RNA extraction from specimen (HCV-3a), cDNA was synthesized that was used to amplify full length core gene of HCV 3a. After verification through PCR, DNA sequencing and BLAST, a properly oriented positive recombinant plasmid for core gene was digested with proper restriction enzymes to release the target gene which was then inserted downstream of GST encoding DNA in the same open reading frame at proper restriction sites in multiple cloning site of pGEX4t2 expression vector. Recombinant expression vector for each gene was transformed in E. coli BL21 (DE3) and induced with IPTG for recombinant fusion protein production that was then purified through affinity chromatography. Western blot and Enzyme Linked Immunosorbant Assay (ELISA) were used to detect immuno-reactivity of the recombinant protein. Results The HCV core antigen produced in prokaryotic expression system was reactive and used to develop a screening assay. After validating the positivity (100%) and negativity (100%) of in-house anti-HCV screening assay through a standardized panel of 200 HCV positive and 200 HCV negative sera, a group of 120 serum specimens of suspected HCV infection were subjected to comparative analysis of our method with commercially available assay. The comparison confirmed that our method is more specific than the commercially available assays for HCV strains circulating in this specific geographical region of the world and could thus be used for HCV screening in Pakistan. Conclusion In this study, we devised a screening assay after successful PCR amplification, isolation, sequencing, expression and purification of core antigen of HCV genotype 3a. Our developed screening assay is more sensitive, specific and reproducible than the commercially available screening assays in Pakistan.en_US
dc.description.sponsorshipThis work was partially supported by the Higher Education Commission (HEC) of Pakistan.en_US
dc.language.isoenen_US
dc.publisherBioMed Centralen_US
dc.relation.ispartofseriesVirology Journal;Volume 8-
dc.titleExpression of core antigen of HCV genotype 3a and its evaluation as screening agent for HCV infection in Pakistanen_US
dc.typeArticleen_US
Appears in Collections:School of Life Sciences

Files in This Item:
File Description SizeFormat 
1743-422X-8-364 (2).pdf947.32 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.